Skip to main content
. 2013 Oct 22;8(10):e78259. doi: 10.1371/journal.pone.0078259

Table 6. Association of CD44+/CD24- Phenotype and Disease Outcome by Study and Multivariate Analysis.

STUDY (REFERENCE) SAMPLE
CD44+/CD24- REDUCED DFS MULTIVARIATE ANALYSIS††
(N) Ethnicity % P-VALUE HR††† (95% CI) P-VALUE
Lin, 2012 [34] 147 Asian 70 0.001* 2.2 (1.3-3.7) 0.002*
Perrone, 2012 [36] 56 Caucasian 91 <0.05 * 6.0 (1.8-19.9) 0.003*
Xu, 2012 [37] 1086 Asian 31 n.s 1.2 (0.8-1.7) 0.32
Giatromanolaki, 2010 [27] 139 Caucasian 29 n.s. 1.3 0.18
Lee, 2011 [33] 92 Asian 40 0.043* - -
Honeth, 2008 [26] 240 Caucasian 31 n/a - -
Mylona, 2008 [35] 155 Caucasian 59 0.074 - -
Abraham, 2005 [24] 136 Caucasian 22 n.s. - -
Kim, 2011 [38] 643 Asian 21 0.003 * 0.7 (0.5-0.9) 0.02*
Vadgama, 2013 126 African-American, Hispanic 29 0.05 * 1.0 (0.5-2.1) 0.9

Abbreviations: DFS-Disease Free Survival, HR-Hazard Ratio, CI–Confidence Interval, n.s–Not Significant (P>0.05). n/a-information is not available, AA-African-American, Hisp-Hispanic/Latina.

* P-value<0.05 is significant.

† Kaplan-Meier Survival analysis with Log-rank test.

†† Adjusted for Tumor Clinicopathology and Age.

††† Hazard Ratio for Reduced DFS.